Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 153

    1.

    Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly.

    Salvatori R, Nachtigall LB, Cook DM, Bonert V, Molitch ME, Blethen S, Chang S; The SALSA Study Group.

    Pituitary. 2009 Nov 8. [Epub ahead of print]PMID: 19898989 [PubMed - as supplied by publisher]Related articles

    2.

    Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?

    Yuen KC, Biller BM, Molitch ME, Cook DM.

    J Clin Endocrinol Metab. 2009 Aug;94(8):2702-7. Epub 2009 Jun 9. Review.PMID: 19509104 [PubMed - indexed for MEDLINE]Related articles

    3.

    A randomized trial of therapies for type 2 diabetes and coronary artery disease.

    BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE.

    N Engl J Med. 2009 Jun 11;360(24):2503-15. Epub 2009 Jun 7.PMID: 19502645 [PubMed - indexed for MEDLINE]Related articles

    4.

    Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.

    Hahr AJ, Molitch ME.

    Am J Ther. 2008 Nov-Dec;15(6):543-50. Review.PMID: 19127139 [PubMed - indexed for MEDLINE]Related articles

    5.

    Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus.

    Layden BT, Dubner S, Toft DJ, Kopp P, Grimm S, Molitch ME.

    Pituitary. 2009 Jan 3. [Epub ahead of print]PMID: 19123039 [PubMed - as supplied by publisher]Related articles

    6.

    The cabergoline-resistant prolactinoma patient: new challenges.

    Molitch ME.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4643-5. No abstract available. PMID: 19056842 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pituitary radiotherapy.

    Molitch ME, Grossman AB.

    Pituitary. 2009;12(1):1-2. No abstract available. PMID: 18946738 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

    de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.

    Arch Intern Med. 2008 Sep 22;168(17):1867-73.PMID: 18809813 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intensive insulin management of inpatient hyperglycemia: the time for implementation is now.

    De Santis A, Molitch ME.

    Acta Biomed. 2008 Apr;79(1):5-8. No abstract available. PMID: 18551815 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemia.

    Liao P, DeSantis AJ, Schmeltz LR, Schmidt K, O'Shea-Mahler E, Victor S, Molitch ME.

    J Diabetes Complications. 2008 Jul-Aug;22(4):229-34. Epub 2008 Apr 16.PMID: 18413197 [PubMed - indexed for MEDLINE]Related articles

    11.

    Drugs and prolactin.

    Molitch ME.

    Pituitary. 2008;11(2):209-18. Review.PMID: 18404390 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lanreotide Autogel in the management of acromegaly.

    Molitch ME.

    Drugs. 2008;68(5):724. No abstract available. PMID: 18370451 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lymphocytic hypophysitis.

    Molitch ME, Gillam MP.

    Horm Res. 2007;68 Suppl 5:145-50. Epub 2007 Dec 10. Review.PMID: 18174733 [PubMed - indexed for MEDLINE]Related articles

    14.

    Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.

    Andress DL, Coyne DW, Kalantar-Zadeh K, Molitch ME, Zangeneh F, Sprague SM.

    Endocr Pract. 2008 Jan-Feb;14(1):18-27. Review.PMID: 18238737 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nonfunctioning pituitary tumors and pituitary incidentalomas.

    Molitch ME.

    Endocrinol Metab Clin North Am. 2008 Mar;37(1):151-71, xi. Review.PMID: 18226735 [PubMed - indexed for MEDLINE]Related articles

    16.

    Management of dyslipidemias in patients with diabetes and chronic kidney disease.

    Molitch ME.

    Clin J Am Soc Nephrol. 2006 Sep;1(5):1090-9. Epub 2006 Jul 26. Review.PMID: 17699330 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prolactin and autoimmune diseases in humans.

    Chuang E, Molitch ME.

    Acta Biomed. 2007;78 Suppl 1:255-61.PMID: 17465339 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.

    Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, Henske J, McCarthy PM, Gleason TG, McGee EC, Molitch ME.

    Diabetes Care. 2007 Apr;30(4):823-8. Epub 2007 Jan 17.PMID: 17229943 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.

    Schmeltz LR, DeSantis AJ, Schmidt K, O'Shea-Mahler E, Rhee C, Brandt S, Peterson S, Molitch ME.

    Endocr Pract. 2006 Nov-Dec;12(6):641-50.PMID: 17229660 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prolactin-secreting tumors: what's new?

    Molitch ME.

    Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S29-35. Review.PMID: 17004854 [PubMed - indexed for MEDLINE]Related articles

    21.

    Inpatient management of hyperglycemia: the Northwestern experience.

    DeSantis AJ, Schmeltz LR, Schmidt K, O'Shea-Mahler E, Rhee C, Wells A, Brandt S, Peterson S, Molitch ME.

    Endocr Pract. 2006 Sep-Oct;12(5):491-505.PMID: 17002924 [PubMed - indexed for MEDLINE]Related articles

    22.

    Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.

    Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A.

    Clin Endocrinol (Oxf). 2006 Aug;65(2):265-73.PMID: 16886971 [PubMed - indexed for MEDLINE]Related articles

    23.

    Advances in the treatment of prolactinomas.

    Gillam MP, Molitch ME, Lombardi G, Colao A.

    Endocr Rev. 2006 Aug;27(5):485-534. Epub 2006 May 26. Review.PMID: 16705142 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.

    Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML; Endocrine Society's Clinical Guidelines Subcommittee, Stephens PA.

    J Clin Endocrinol Metab. 2006 May;91(5):1621-34. Epub 2006 Apr 24. Review.PMID: 16636129 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program.

    Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME; Diabetes Prevention Program Research Group.

    Diabetes Care. 2006 Apr;29(4):914-9.PMID: 16567837 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Prolactin excess: treatment and toxicity.

    Gillam MP, Fideleff H, Boquete HR, Molitch ME.

    Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:108-14. Review.PMID: 16456489 [PubMed - indexed for MEDLINE]Related articles

    27.

    Pharmacologic resistance in prolactinoma patients.

    Molitch ME.

    Pituitary. 2005;8(1):43-52. Review.PMID: 16411068 [PubMed - indexed for MEDLINE]Related articles

    28.

    Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes.

    Molitch ME, Rupp D, Carnethon M.

    Diabetes Care. 2006 Jan;29(1):78-82.PMID: 16373900 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Pituitary disorders during pregnancy.

    Molitch ME.

    Endocrinol Metab Clin North Am. 2006 Mar;35(1):99-116, vi. Review. No abstract available. PMID: 16310644 [PubMed - indexed for MEDLINE]Related articles

    30.

    The incidence of Sheehan's syndrome after obstetric hemorrhage.

    Feinberg EC, Molitch ME, Endres LK, Peaceman AM.

    Fertil Steril. 2005 Oct;84(4):975-9.PMID: 16213852 [PubMed - indexed for MEDLINE]Related articles

    31.

    Medication-induced hyperprolactinemia.

    Molitch ME.

    Mayo Clin Proc. 2005 Aug;80(8):1050-7. Review.PMID: 16092584 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Screening for kidney disease in adults with diabetes.

    Kramer H, Molitch ME.

    Diabetes Care. 2005 Jul;28(7):1813-6. No abstract available. PMID: 15983346 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The pituitary mass: diagnosis and management.

    Sam S, Molitch ME.

    Rev Endocr Metab Disord. 2005 Jan;6(1):55-62. Review. No abstract available. PMID: 15711915 [PubMed - indexed for MEDLINE]Related articles

    34.

    How long should insulin be used once a vial is started?

    Molitch ME.

    Diabetes Care. 2004 May;27(5):1240-1; author reply 1241-2. No abstract available. PMID: 15111563 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Nephropathy in diabetes.

    Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW; American Diabetes Association.

    Diabetes Care. 2004 Jan;27 Suppl 1:S79-83. No abstract available. PMID: 14693934 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Cortisol levels and mortality in severe sepsis.

    Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME.

    Clin Endocrinol (Oxf). 2004 Jan;60(1):29-35.PMID: 14678284 [PubMed - indexed for MEDLINE]Related articles

    37.

    Dopamine resistance of prolactinomas.

    Molitch ME.

    Pituitary. 2003;6(1):19-27. Review.PMID: 14674720 [PubMed - indexed for MEDLINE]Related articles

    38.

    Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile.

    Drincic A, Arseven OK, Sosa E, Mercado M, Kopp P, Molitch ME.

    Pituitary. 2003;6(1):5-10.PMID: 14674718 [PubMed - indexed for MEDLINE]Related articles

    39.

    Pituitary tumors and pregnancy.

    Molitch ME.

    Growth Horm IGF Res. 2003 Aug;13 Suppl A:S38-44. Review.PMID: 12914726 [PubMed - indexed for MEDLINE]Related articles

    40.

    The diabetes prevention program and its global implications.

    Molitch ME, Fujimoto W, Hamman RF, Knowler WC; Diabetes Prevention Program Research Group.

    J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S103-7.PMID: 12819312 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Timing and special concerns regarding endocrine surgery during pregnancy.

    Sam S, Molitch ME.

    Endocrinol Metab Clin North Am. 2003 Jun;32(2):337-54. Review.PMID: 12800535 [PubMed - indexed for MEDLINE]Related articles

    42.

    Medical management of prolactin-secreting pituitary adenomas.

    Molitch ME.

    Pituitary. 2002;5(2):55-65. Review.PMID: 12675502 [PubMed - indexed for MEDLINE]Related articles

    43.

    The relationship between glucose control and the development and progression of diabetic nephropathy.

    Phillips CA, Molitch ME.

    Curr Diab Rep. 2002 Dec;2(6):523-9. Review.PMID: 12643159 [PubMed - indexed for MEDLINE]Related articles

    44.

    Diabetic nephropathy.

    Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH; American Diabetes Association.

    Diabetes Care. 2003 Jan;26 Suppl 1:S94-8. No abstract available. PMID: 12502629 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.

    Gillam MP, Middler S, Freed DJ, Molitch ME.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4447-51.PMID: 12364416 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Inappropriate prescription for metformin.

    Molitch ME.

    JAMA. 2002 Aug 14;288(6):694; author reply 694-5. No abstract available. PMID: 12169060 [PubMed - indexed for MEDLINE]Related articles

    47.

    Diagnosis of GH deficiency in adults--how good do the criteria need to be?

    Molitch ME.

    J Clin Endocrinol Metab. 2002 Feb;87(2):473-6. Review. No abstract available. PMID: 11836271 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Disorders of prolactin secretion.

    Molitch ME.

    Endocrinol Metab Clin North Am. 2001 Sep;30(3):585-610. Review.PMID: 11571932 [PubMed - indexed for MEDLINE]Related articles

    49.

    Endocrine problems in the chronically critically ill patient.

    Vasa FR, Molitch ME.

    Clin Chest Med. 2001 Mar;22(1):193-208.PMID: 11315456 [PubMed - indexed for MEDLINE]Related articles

    50.

    Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial.

    Thomas W, Shen Y, Molitch ME, Steffes MW.

    J Am Soc Nephrol. 2001 Feb;12(2):333-40.PMID: 11158223 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...